To explore the clinical value of impedance echocardiography in the exercise risk assessment of stroke patients with coronary heart disease

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100048578

Enrollment

Unknown

Registered

2021-07-11

Start date

2021-07-08

Completion date

Unknown

Last updated

2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

Stroke combined with coronary heart disease group:No

Stroke patients:No

Control group:No

Eligibility

Sex/Gender

All

Age

50 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. The first onset of cerebral infarction or cerebral hemorrhage; 2. Combined with stable angina pectoris, asymptomatic myocardial ischemia after percutaneous coronary intervention (percutaneous coronary intervention, PCI) after revascularization, percutaneous transluminal coronary angioplasty (percutaneous transluminal angioplasty) coronary angioplasty (PTCA), coronary artery bypass grafting (CABG)], coronary heart disease including controlled heart failure, left ventricular ejection fraction (LVEF) >= 40 %, and cardiac rehabilitation risk stratification is low and intermediate risk; 3. Aged 50 to 70 years; 4. Hemiplegia of limbs, sitting balance >= grade 2, Brunnstrom motor function classification grade III or above, able to complete limb linkage training and 6-min walking test; 5. The patient and his family voluntarily signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. The patient has cognitive or mental disorders; 2. The onset time is less than 2 weeks; 3. Severe arrhythmia, cardiac function grade 4; 4. Moderate and above aortic stenosis; 5. Resting systolic blood pressure > 160 mmHg or resting diastolic blood pressure > 100 mmHg; 6. Coronary heart disease accompanied by acute complications (such as acute vascular occlusion including stent thrombosis, coronary artery tear, etc.); 7. Severe infection, water, electrolyte and metabolism are obviously abnormal; 8. Active period of pericarditis or myocarditis; 9. There are new deep vein thrombosis, thrombophlebitis, lower extremity occlusive arteriosclerosis, aortic dissection and other aneurysms; 10. Combined with chronic obstructive pulmonary disease.

Design outcomes

Primary

Measure	Time frame
hemodynamic parameters;	—

Countries

China

Contacts

Public ContactWang Yao

Shenzhen Dapeng New District Nan'ao people's Hospital

13609615348@163.com+86 13609615348

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026